BackDecision Diagnostics Overview

Decision Diagnostics Accounts Payable

Track Decision Diagnostics's accounts payable ($1.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.56M
↓ 5.18% YoYΔ $-85536.00 vs prior year quarter

Peer trimmed avg / median

Loading

Decision Diagnostics Accounts Payable History

Loading

Decision Diagnostics vs. peers: Accounts Payable Comparison

Loading

Decision Diagnostics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Decision Diagnostics (DECN) FAQ

Decision Diagnostics's accounts payable stands at $1.6M as of September 2021. That compares with $1.6M in the prior-year period — down 5.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Decision Diagnostics reported $1.6M in accounts payable versus $1.6M a year earlier — a 5.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.6M in the prior-year period — down 5.2% year over year. Sustained growth in accounts payable can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Decision Diagnostics's accounts payable evolved across reporting periods, while the comparison chart places DECN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers